Globalisation

(Image: Getty/mthipsorn)

Takeda secures Shire bid for $62.11bn

By Melissa Fassbender

Takeda has acquired Shire for approximately $62.11bn (£46bn) to create a Japan-headquartered biopharmaceutical company with a robust pipeline and expanded geographical footprint.